Ets-1 Regulates TNF-α-Induced Matrix Metalloproteinase-9 and Tenascin Expression in Primary Bronchial Fibroblasts1
暂无分享,去创建一个
James S. Malter | Nizar N. Jarjour | Elizabeth A. B. Kelly | Yutaka Nakamura | N. Jarjour | E. A. Kelly | S. Esnault | J. Malter | T. Maeda | Yutaka Nakamura | Stéphane Esnault | Takashi Maeda
[1] N. Jarjour,et al. Role of matrix metalloproteinases in asthma , 2003, Current opinion in pulmonary medicine.
[2] J. Pfeilschifter,et al. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors. , 2002, Molecular endocrinology.
[3] Inge Nelissen,et al. Gelatinase B functions as regulator and effector in leukocyte biology , 2001, Journal of leukocyte biology.
[4] O. Lider,et al. Transforming growth factor‐β suppresses tumor necrosis factor α‐induced matrix metalloproteinase‐9 expression in monocytes , 2001, Journal of leukocyte biology.
[5] M. Bates,et al. Granulocyte macrophage colony-stimulating factor and interleukin-5 activate STAT5 and induce CIS1 mRNA in human peripheral blood eosinophils. , 2001, American journal of respiratory cell and molecular biology.
[6] M. Abe,et al. Molecular Cloning and Characterization of a Novel Gene,CORS26, Encoding a Putative Secretory Protein and Its Possible Involvement in Skeletal Development* , 2001, The Journal of Biological Chemistry.
[7] A. Sharrocks,et al. The ETS-domain transcription factor family. , 1997, Nature reviews. Molecular cell biology.
[8] W. Busse,et al. Increased matrix metalloproteinase-9 in the airway after allergen challenge. , 2000, American journal of respiratory and critical care medicine.
[9] L. Matrisian,et al. Matrix metalloproteinases: multifunctional contributors to tumor progression. , 2000, Molecular medicine today.
[10] B. Fingleton,et al. Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] D. Watson,et al. Ets transcription factors cooperate with Sp1 to activate the human Tenascin-C promoter , 1999, Oncogene.
[12] R. Moqbel,et al. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. , 1999, The Journal of allergy and clinical immunology.
[13] G. Breier,et al. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. , 1999, Blood.
[14] A. Cano,et al. Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element. , 1999, Experimental cell research.
[15] A. Nordheim,et al. Regulation of the Human Interleukin-5 Promoter by Ets Transcription Factors , 1999, The Journal of Biological Chemistry.
[16] D. Hartmann,et al. Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. , 1999, American journal of respiratory and critical care medicine.
[17] S. Isogai,et al. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. , 1998, The Journal of allergy and clinical immunology.
[18] M. Tymms,et al. The role of Ets-1 in mast cell granulocyte-macrophage colony-stimulating factor expression and activation. , 1998, Journal of immunology.
[19] L. Wahl,et al. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. , 1998, Journal of immunology.
[20] A. Newby,et al. Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κB , 1998, FEBS letters.
[21] M A Moses,et al. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. , 1998, Stem cells.
[22] I. Virtanen,et al. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. , 1997, American journal of respiratory and critical care medicine.
[23] M. Meisterernst,et al. A conserved tissue-specific structure at a human T-cell receptor beta-chain core promoter , 1997, Molecular and cellular biology.
[24] J. Lautenberger,et al. Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. , 1997, Cancer research.
[25] M. Moses. The Regulation of Neovascularization by Matrix Metalloproteinases and Their Inhibitors , 1997 .
[26] S. Hoffman,et al. IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts. , 1996, The Journal of investigative dermatology.
[27] M. Shibuya,et al. A cAMP Response Element and an Ets Motif Are Involved in the Transcriptional Regulation of flt-1 Tyrosine Kinase (Vascular Endothelial Growth Factor Receptor 1) Gene* , 1996, The Journal of Biological Chemistry.
[28] H. Nagase,et al. Tumor necrosis factor α (TNFα) induces pro‐matrix metalloproteinase 9 production in human uterine cervical fibroblasts but interleukin 1 α antagonizes the inductive effect of TNFα , 1996 .
[29] E. Lengyel,et al. Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences (*) , 1996, The Journal of Biological Chemistry.
[30] B. Vandenbunder,et al. The c-ets-1 proto-oncogene is a new early-response gene differentially regulated by cytokines and growth factors in human fibroblasts. , 1996, Experimental cell research.
[31] Z. Werb,et al. Synergistic Transcriptional Activation of the Tissue Inhibitor of Metalloproteinases-1 Promoter via Functional Interaction of AP-1 and Ets-1 Transcription Factors (*) , 1996, The Journal of Biological Chemistry.
[32] J. Virchow,et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. , 1995, American journal of respiratory and critical care medicine.
[33] G. Henkel,et al. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[34] P. Petrides,et al. Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion. , 1994, Blood.
[35] H. Merker. Morphology of the basement membrane , 1994, Microscopy research and technique.
[36] C. O'connor,et al. Matrix metalloproteases and lung disease. , 1994, Thorax.
[37] P. Howarth,et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. , 1994, American journal of respiratory cell and molecular biology.
[38] J. Girard,et al. Expression and cellular localization of glucose transporters (GLUT1, GLUT3, GLUT4) during differentiation of myogenic cells isolated from rat foetuses. , 1994, Journal of cell science.
[39] H. Erickson,et al. Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. , 1994, Journal of cell science.
[40] H. Sato,et al. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. , 1993, The Journal of biological chemistry.
[41] A. Malik,et al. A 96-kDa gelatinase induced by TNF-alpha contributes to increased microvascular endothelial permeability. , 1993, The American journal of physiology.
[42] H. Sato,et al. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. , 1993, Oncogene.
[43] B. Wasylyk,et al. The Ets family of transcription factors. , 1993, European journal of biochemistry.
[44] A. Newby,et al. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. , 1992, The Biochemical journal.
[45] P. Paré,et al. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.
[46] P. Jeffery,et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. , 1992, The American review of respiratory disease.
[47] N. Bhat,et al. Sequence-specific binding of human Ets-1 to the T cell receptor alpha gene enhancer. , 1990, Science.
[48] J. Bousquet,et al. Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.
[49] G. Edelman,et al. Identification and characterization of the promoter for the cytotactin gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Holgate,et al. SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS , 1989, The Lancet.